The Board has appointed Mr. Umesh Kumar (DIN: 07015921) as an Additional Executive Director of the Company w.e.f 09th February, 2026 a brief profile pursuant to SEBI Circular dated CIR/CFD/CMD/4/2015 ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Limited has appointed Mr. Umesh Kumar (DIN: 07015921) as an Additional Executive Director of the company, effective February 9, 2026. The appointment was approved at a board meeting held on the same day, which ran from 5:15 p.m. to 5:45 p.m. The company has confirmed that Mr. Kumar is not related to any existing directors or key managerial personnel and is not debarred from holding a director's office by SEBI or any other authority. A brief profile and a self-declaration of non-debarment have been submitted along with the announcement.
This is a routine board-level appointment with no immediate material impact on shareholders. Investors should watch for further clarity on Mr. Kumar's specific roles and responsibilities within the company.